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Mammalian spermatogenesis—the transformation of stem cells
into millions of haploid spermatozoa—is elaborately organized
in time and space. We explored the underlying regulatory mecha-
nisms by genetically and chemically perturbing spermatogenesis in
vivo, focusing on spermatogonial differentiation, which begins a
series of amplifying divisions, and meiotic initiation, which ends
these divisions. We first found that, in mice lacking the retinoic acid
(RA) target gene Stimulated by retinoic acid gene 8 (Stra8), undif-
ferentiated spermatogonia accumulated in unusually high numbers
as early as 10 d after birth, whereas differentiating spermatogonia
were depleted.We thus conclude that Stra8, previously shown to be
required for meiotic initiation, also promotes (but is not strictly re-
quired for) spermatogonial differentiation. Second, we found that
injection of RA into wild-type adult males induced, independently,
precocious spermatogonial differentiation and precocious meiotic
initiation; thus, RA acts instructively on germ cells at both transi-
tions. Third, the competencies of germ cells to undergo spermato-
gonial differentiation or meiotic initiation in response to RA were
found to be distinct, periodic, and limited to particular seminiferous
stages. Competencies for both transitions begin while RA levels are
low, so that the germ cells respond as soon as RA levels rise. To-
gether with other findings, our results demonstrate that periodic
RA–STRA8 signaling intersects with periodic germ-cell competencies
to regulate two distinct, cell-type-specific responses: spermatogo-
nial differentiation and meiotic initiation. This simple mechanism,
with one signal both starting and ending the amplifying divisions,
contributes to the prodigious output of spermatozoa and to the
elaborate organization of spermatogenesis.
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The adult mammalian testis is among the body’s most pro-liferative tissues, producing millions of highly specialized
gametes, or spermatozoa, each day. Spermatogenesis (the pro-
gram of sperm production) is carefully regulated, ensuring that
spermatozoa are produced at a constant rate. We used the mouse
as a model to understand how mammalian spermatogenesis is
organized at the cellular and molecular level. We focused on
two key transitions: spermatogonial differentiation, which oc-
curs cyclically and begins a series of programmed mitotic di-
visions, and meiotic initiation, which ends these divisions and
marks the beginning of the meiotic program (Fig. 1A).
Like other proliferative tissues (e.g., blood, intestine, and
skin), the testis relies on a modest number of stem cells (1, 2).
The undifferentiated spermatogonia (also known as the Asingle/
Apaired/Aaligned spermatogonia), which encompass these stem
cells, have a remarkable capacity for self-renewal and differen-
tiation: They can reconstitute spermatogenesis upon transplantation
to a germ-cell-depleted testis (3, 4). In vivo, undifferentiated sper-
matogonia ultimately give rise to a single cell type, spermatozoa, yet
these undifferentiated spermatogonia express pluripotency-associ-
ated genes such as Lin28a (Lin-28 homolog A) (5) and Pou5f/Oct4
(6, 7) and are the only postnatal mammalian cells from which
functionally pluripotent cells have been derived in vitro without
introduction of exogenous transcription factors or miRNAs (8).
Undifferentiated spermatogonia periodically undergo spermato-
gonial differentiation (also known as the Aaligned-to-A1 transi-
tion) to become differentiating spermatogonia (also known as
A1/A2/A3/A4/intermediate/B spermatogonia). During spermatogo-
nial differentiation, the spermatogonia down-regulate pluripotency-
associated genes (5, 9), lose capacity for self-renewal (4), and ac-
celerate their cell cycle (10) to begin a series of six transit-amplifying
mitotic ivisions. At the conclusion of these mitotic divisions,
germ cells become spermatocytes, and undergo meiotic initiation
(Fig. 1A). This begins the meiotic program of DNA replication
and reductive cell divisions, ensuring that spermatozoa contribute
exactly one of each chromosome to the zygote.
Meiotic initiation is precisely coordinated with spermatogonial
differentiation: The six mitotic divisions separating the two
transitions occur over a span of exactly 8.6 d (11). Moreover,
spermatogonial differentiation and meiotic initiation occur in
close physical proximity. The testis comprises structures known
as seminiferous tubules (Fig. S1A); while one generation of germ
cells is initiating meiosis, a younger generation is simultaneously
undergoing spermatogonial differentiation, within the same tubule
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cross-section (Fig. 1B and Fig. S1A). Spermatogonial differentiation
and meiotic initiation occur in close association not only in mice but
also in other mammals, including rats (12, 13), hamsters, and rams
(14). This precise coordination of different steps of spermatogenesis
is called the “cycle of the seminiferous epithelium” (or “seminif-
erous cycle”); it has fascinated biologists for over a century (15). We
sought to explain the cooccurrence of spermatogonial differentia-
tion and meiotic initiation, to better understand the regulation of
these two transitions and the overall organization of the testis.
Both of these transitions require RA, a derivative of vitamin
A. In vitamin A-deficient (VAD) mice and rats, most germ cells
arrest as undifferentiated spermatogonia (16, 17). In VAD rat
testes, some germ cells instead arrest just before meiosis, as
preleptotene spermatocytes (16, 18). When VAD animals are
injected with RA or vitamin A, the arrested spermatogonia dif-
ferentiate (17–19), and the arrested preleptotene spermatocytes
initiate meiosis (18). During spermatogonial differentiation, RA
is believed to act, at least in part, directly on germ cells: Sper-
matogonia express RA receptors (RARs) (20), and genetic ab-
lation of RARs in germ cells modestly impairs spermatogonial
differentiation (21).
To understand how RA might coregulate these two transi-
tions, we needed to understand its target genes. During meiotic
initiation, RA acts instructively, through the target gene Stra8
(Stimulated by retinoic acid gene 8). RA induces Stra8 expression
in germ cells—not in somatic cells—in both males and females
(22, 23). Stra8 is required for meiotic initiation in both sexes:
Stra8-deficient germ cells in postnatal males and fetal females
arrest just before meiosis, without entering meiotic prophase (24,
25). In contrast, no specific RA target genes have been impli-
cated in spermatogonial differentiation: RA could either instruct
the germ cells or simply be permissive for this transition. We
considered Stra8 as a candidate regulator of spermatogonial
differentiation: STRA8 protein is expressed in spermatogonia as
well as in preleptotene spermatocytes in vivo (26, 27), and in
vitro studies suggest that RA can act directly on early sper-
matogonia to increase expression of Stra8 (28). However, the
functional role, if any, of Stra8 in spermatogonia was not pre-
viously known. Using two complementary perturbations of RA–
STRA8 signaling—genetic disruption of Stra8 function and
chemical manipulation of RA levels—we demonstrated that RA
acts instructively, and at least in part through STRA8, at sper-
matogonial differentiation as well as at meiotic initiation. The
shared RA–STRA8 signal helps to coordinate these two transi-
tions in time and space.
Results
Massive Accumulations of Type A Spermatogonia in Testes of Aged
Stra8-Deficient Males. As we previously reported, Stra8-deficient
testes lacked meiotic and postmeiotic cells (24, 25); thus, at 8 wk
of age, Stra8-deficient testes were much smaller than wild-type
testes (25). However, we observed that, after 6 mo, some Stra8-
deficient testes were grossly enlarged (>400 mg) (44%; 11 of 25
mice) compared with wild-type testes (91 ± 7 mg; average of
testes from three mice) (Fig. 2A). Both small and large aged
Stra8-deficient testes (88%; 22 of 25 mice) contained accumu-
lated cells that resembled spermatogonia and expressed the
germ-cell marker DAZL (Fig. 2B); these accumulations were
absent in aged wild-type and heterozygous mice (0%, 0 of 10
mice). In wild-type testes, spermatogonia were confined to the
basal lamina of seminiferous tubules, but even in small Stra8-
deficient testes (<50 mg) occasional tubules were filled with
presumptive spermatogonia, which sometimes spilled into the
testicular interstitium. Large Stra8-deficient testes were com-
posed almost entirely of presumptive spermatogonia, with few
remnants of tubule structure. Spermatogonial morphology was
very similar between small and large Stra8-deficient testes. We
used mRNA sequencing (mRNA-Seq) to confirm that sper-
matogonia had accumulated in Stra8-deficient testes; known
spermatogonial marker genes (29) were up-regulated in Stra8-
deficient testes vs. wild-type testes (Fig. S2A).
We classified more precisely the spermatogonia in these
massive accumulations. Based on nuclear morphology, sper-
matogonia can be classified as type A, intermediate, or type B
(Fig. 1 A and B) (11). Type A includes the undifferentiated and
early differentiating spermatogonia, whereas intermediate and
type B encompass the later differentiating spermatogonia. The
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Fig. 1. Overview of spermatogenesis. (A) Diagram of mouse spermato-
genesis. Germ cells develop from undifferentiated, mitotic spermato-
gonia (red, bottom left), to differentiating spermatogonia (purple,
middle left), to spermatocytes (germ cells that undergo meiosis, green,
middle right), to haploid spermatids (gray, top right). We highlight
two cellular differentiation steps: spermatogonial differentiation and
meiotic initiation. (B) Diagram of germ-cell associations (stages) in the
mouse testis. Oakberg (33) identified 12 distinct cellular associations,
called seminiferous stages I–XII. In the mouse, it takes 8.6 d for a section
of the seminiferous tubule, and the germ cells contained within, to cycle
through all 12 stages (41). Four turns of this seminiferous cycle are re-
quired for a germ cell to progress from undifferentiated spermatogo-
nium to spermatozoon that is ready to be released into the tubule
lumen. Aundiff, Adiff, In, and B: undifferentiated type A, differentiating
type A, intermediate, and type B spermatogonia, respectively. D, L, P, Pl,
SC2, and Z: diplotene, leptotene, pachytene, preleptotene, secondary
spermatocytes, and zygotene, respectively. Steps 1–16: steps in sperma-
tid differentiation. Purple: germ cells undergoing spermatogonial differ-
entiation; green: meiotic initiation.
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Stra8-deficient spermatogonia had type A morphology (Fig. 2B).
To confirm this, we used mRNA-Seq to identify the 100 genes
most significantly up-regulated in Stra8-deficient vs. wild-type
testes (Table S1). We analyzed their expression among different
cell types in wild-type testes, using a published microarray dataset
(30); 59% of these 100 genes were most highly expressed in type A
spermatogonia, vs. 22.7% of a control gene set (all 17,345 genes
on the microarray) (Fig. 2C) (P < 0.001, Fisher’s exact test). A
genome-wide clustering analysis of these data and other publically
available datasets confirmed that the expression patterns of Stra8-
deficient testes were overall quite similar to those of type A
spermatogonia (Fig. S2B and SI Results and Discussion). We
conclude that type A spermatogonia accumulate in Stra8-deficient
testes. This suggests that STRA8 has a functional role in type A
spermatogonia, distinct from its role in meiotic initiation.
Early Postnatal Stra8-Deficient Testes Contain Accumulations of
Undifferentiated Spermatogonia and Are Depleted for Differentiating
Spermatogonia. We considered our findings in light of published
observations that (i) a subset of type A spermatogonia undergo
spermatogonial differentiation, (ii) RA is required for spermato-
gonial differentiation (17, 18), and (iii) RA can act directly on
spermatogonia to induce Stra8 expression (28). We postulated
that in the unperturbed wild-type testis, RA induction of Stra8
promotes spermatogonial differentiation, whereas in the absence
of Stra8, impaired spermatogonial differentiation leads to ac-
cumulation of undifferentiated spermatogonia, accounting for
the massive accumulations of type A spermatogonia observed in
aged Stra8-deficient males.
This hypothesis predicts that even in very young males Stra8-
deficient testes should contain more undifferentiated spermatogonia
than wild-type testes. To test this, we counted undifferentiated
spermatogonia in testes from 10-d-old (p10) animals (Fig. 3 A and B
and Fig. S3 A and B), using the markers LIN28A and PLZF
(promyelocytic leukemia zinc finger, a.k.a. ZBTB16) (9, 31). As
predicted, LIN28- and PLZF-positive spermatogonia were enriched
in Stra8-deficient testes (P < 10−15 for LIN28A, P < 10−4 for
PLZF, one-tailed Kolmogorov–Smirnov test) (Fig. 3B and Fig. S3B).
Stra8-deficient testes had 9.4 ± 2.3 LIN28A-positive spermato-
gonia per tubule cross-section, vs. 4.4 ± 0.8 in wild-type testes (P =
0.026, one-tailed Welch’s t test). As the testis matured, the
number of undifferentiated spermatogonia per tubule cross-
section declined in both wild-type and Stra8-deficient testes, but
undifferentiated spermatogonia remained significantly enriched in
Stra8-deficient testes at p30 (Fig. 3C and Fig. S3C). Indeed, some
testis tubules in p30 Stra8-deficient mice contained large clusters of
LIN28A-positive and PLZF-positive type A spermatogonia (Fig. 3D
and Fig. S3E). Spermatogonia in these clusters were densely packed
in multiple layers, whereas in wild-type testes type A spermatogonia
were widely spaced in a single layer (Fig. S3D). Thus, we conclude
that undifferentiated spermatogonia progressively accumulate in
Stra8-deficient animals. mRNA-Seq and immunohistochemical data
from testes of aged Stra8-deficient mice were consistent with such
an accumulation (Fig. S2 B–E and SI Results and Discussion).
If this progressive accumulation were due to a defect in
spermatogonial differentiation, the proportion of differentiating
spermatogonia should be smaller in Stra8-deficient testes than in
wild-type testes. We thus counted type B (differentiating) sper-
matogonia in Stra8-deficient and wild-type testes at p30 (Fig. 3C
and Fig. S3F). Indeed, compared with wild-type testes, Stra8-
deficient testes contained significantly fewer type B spermatogonia
per tubule cross-section. As predicted, the ratio of differentiating-
to-undifferentiated (LIN28-positive) spermatogonia was decreased
to 2.8 in Stra8-deficient testes, vs. 7.9 in wild-type testes (P = 0.05 by
Mann–Whitney U test). We conclude that STRA8 promotes (but is
not strictly required for) spermatogonial differentiation.
STRA8 Expression Begins Shortly Before Spermatogonial Differentiation.
Previous reports showed that STRA8 is expressed in spermatogonia
and spermatocytes but did not distinguish between different sub-
types of spermatogonia (26, 27). We tested our model’s prediction
that STRA8 must be expressed before or during spermatogonial
differentiation, immunostaining intact testis tubules for STRA8
and for PLZF (Fig. 4A and Fig. S4A). A subset of PLZF-positive
(undifferentiated) spermatogonia expressed STRA8. We next
immunostained for GFRα1 (GDNF family receptor alpha 1), a
marker of early undifferentiated spermatogonia (Fig. S4A)
(32). GFRα1 did not overlap with STRA8. We thus hypothesized
that STRA8 expression begins immediately before spermatogonial
differentiation.
To confirm this, we immunostained testis sections for STRA8
and then classified tubules by stage of the cycle of the seminif-
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Fig. 2. Aged Stra8-deficient testes accumulate type A spermatogonia. (A) Wild-type (left) and Stra8-deficient small (center) and large (right) testes from 1-y-
old mice. (Scale bar, 5 mm.) (B) Testis sections from 1-y-old mice: wild-type (Top), Stra8-deficient small testis (Middle), and Stra8-deficient grossly enlarged
testis (Bottom). (Left) H&E staining (Right) DAZL immunostaining. Insets enlarge the boxed regions. (Scale bars, 50 μm.) (C) Percentage of genes whose highest
expression is found in type A spermatogonia, type B spermatogonia, pachytene spermatocytes, or round spermatids. Black bars (control), all analyzable genes
(17,345 genes). Gray bars, 100 genes most significantly up-regulated in Stra8-deficient large testes relative to wild-type testes (Table S1).
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erous epithelium (hereafter referred to as “seminiferous stage”)
(Fig. 1B and Fig. S1B). In the testis, particular germ-cell types
are always found in the same tubule cross-section; Oakberg (33)
identified 12 such stereotypical associations of germ cells, called
stages I–XII. Any given section of a seminiferous tubule cycles
through all 12 stages in order, with a full seminiferous cycle
encompassing these stages taking 8.6 d. Spermatogonial differ-
entiation and meiotic initiation occur together in stages VII/VIII.
Consistent with our hypothesis, STRA8 expression was rare in
stages II–VI (before spermatogonial differentiation) then in-
creased rapidly in stages VII–VIII (during spermatogonial dif-
ferentiation) and remained high thereafter, in stages IX–I (Fig.
S1C). [Similar increases in STRA8 expression in stage VII or
VIII have been previously reported (34, 35)]. We further find that
STRA8 expression overlapped with PLZF in stages VII–VIII and
was limited to PLZF-low and -negative spermatogonia thereafter,
in stages IX–X (Fig. 4 A and B and Fig. S4A). We thus conclude
that STRA8 expression begins in late undifferentiated spermato-
gonia and persists in differentiating spermatogonia.
Intriguingly, in stages VII–VIII, STRA8 expression increased
in preleptotene spermatocytes (premeiotic cells) as well as in
undifferentiated spermatogonia (Fig. S1 D and E) (27, 35). Be-
cause STRA8 promotes spermatogonial differentiation and is
required for meiotic initiation, precisely timed increases in
STRA8 expression might coordinate both transitions, ensur-
ing their cooccurrence in stages VII–VIII.
STRA8 expression is induced by RA (22, 23, 26, 28). We hy-
pothesized that RA, acting through Stra8, coordinates sper-
matogonial differentiation with meiotic initiation. To test this,
we perturbed RA signaling in the testes of wild-type mice, by
injecting either RA or WIN18,446, an inhibitor of RA synthesis
(36, 37). We first predicted that injected RA would induce ec-
topic STRA8 expression both in undifferentiated spermatogonia
and in premeiotic cells (differentiating spermatogonia/preleptotene
spermatocytes). Furthermore, injected RA should induce both
precocious spermatogonial differentiation and precocious meiotic
initiation. In contrast, WIN18,446 should inhibit STRA8 expres-
sion, spermatogonial differentiation, and meiotic initiation. We
proceeded to test these predictions.
Injected RA Induces Precocious STRA8 Expression in Both Undifferentiated
Spermatogonia and Premeiotic Germ Cells. We first verified that
injected RA induced precocious STRA8 protein expression in
the spermatogonial population, which encompasses both un-
differentiated spermatogonia and premeiotic cells. In the un-
perturbed wild-type testis, spermatogonia began to express
STRA8 in stages VII–VIII (during spermatogonial differenti-
ation/meiotic initiation) (Fig. 4C). At 1 d after RA injection,
STRA8 expression was strongly induced in spermatogonia in
stages II–VI (Fig. 4C), as previously reported (34). In contrast,
when we treated mice for 2 d with the RA synthesis inhibitor
WIN18,446, spermatogonial STRA8 expression was almost
completely eliminated in all stages (Fig. 4 C and D).
We next showed that injected RA induced precocious STRA8
expression specifically in undifferentiated spermatogonia, by
staining testis sections and intact testis tubules for STRA8 and
PLZF (Fig. 4 A, B, and E and Fig. S4 A and B). Indeed, after RA
injection, STRA8 expression was strongly induced in a subset
of undifferentiated spermatogonia. STRA8 was not induced in
any undifferentiated spermatogonia in stages IX–X, but only
in late undifferentiated spermatogonia in stages II–VI. We conclude
that a very specific subset of undifferentiated spermatogonia is
competent to express STRA8.
Finally, we demonstrated that injected RA could induce pre-
cocious STRA8 expression in premeiotic cells, which we identified
by nuclear morphology and by absence of PLZF expression (Fig.
S4C). In the unperturbed testis, STRA8 was expressed in pre-
leptotene spermatocytes in stages VII–VIII (during meiotic initi-
ation) but was otherwise absent in premeiotic cells (Fig. 4F and
Fig. S4D). After RA injection, STRA8 was strongly induced in all
premeiotic cells, including intermediate and type B spermatogonia
and preleptotene spermatocytes, in stages II–VI. We conclude
that both undifferentiated spermatogonia and premeiotic cells
precociously express STRA8 when exposed to RA in vivo.
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Schiff (He-PAS) staining. (Middle) Grayscale version of top panel, with red
dots indicating type A spermatogonia. (Bottom) LIN28A immunostaining on
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Injected RA Induces Precocious Spermatogonial Differentiation. Be-
cause injected RA induced precocious STRA8 expression in stages
II–VI, and STRA8 promotes spermatogonial differentiation, we
hypothesized that RA would also induce spermatogonial differenti-
ation in these stages. In the unperturbed testis, as a consequence of
their differentiation in stages VII–VIII, spermatogonia express KIT
protooncogene and enter mitotic S phase. They eventually develop
into type B spermatogonia, then become preleptotene spermato-
cytes, and then initiate meiosis to become leptotene spermatocytes.
We predicted that RA injection would cause undifferentiated sper-
matogonia to precociously begin this developmental progression.
We first confirmed that RA injection induced precocious KIT
expression in spermatogonia. In control testis sections, KIT ex-
pression was absent in type A spermatogonia in stages II–VI and
present in stages VII–VIII (Fig. S4 E andG) (7). As predicted, at
1 d after RA injection, KIT was strongly induced in stages II–VI.
We next tested for precocious entry into S phase, using PLZF to
identify undifferentiated and newly differentiating spermatogo-
nia, and BrdU incorporation to assay for S phase (Fig. S4 F and H).
Indeed, at 1 d after RA injection, many PLZF-positive spermato-
gonia in stages II–VIII incorporated BrdU, whereas in control testes
BrdU incorporation did not begin until stage VIII (10, 38).
If injected RA had induced precocious spermatogonial differen-
tiation, the spermatogonia should develop into type B spermato-
gonia, preleptotene spermatocytes, and leptotene spermatocytes
after 7, 8.6, and 10.6 d, respectively (Figs. 1B and 5A) (11). Thus, we
should see transient increases in these cell types. As predicted, at 7 d
after RA injection, type B spermatogonia were present in an
increased fraction of testis tubules, in a much broader range of
stages (XII–VI) than in control testes (IV–VI) (Fig. 5 B and C and
Fig. S5A). Preleptotene spermatocytes were similarly increased at
8.6 d after RA injection (in stages II–VIII, vs. VI–VIII in control
testes) (Fig. 5 D and E and Fig. S5B); throughout these stages, most
of the premeiotic cells in the tubule cross-sections were preleptotene
spermatocytes (Fig. S5D). Finally, at 10.6 d after RA injection,
leptotene spermatocytes were present in an increased fraction of
tubules, throughout stages VI–X (vs. VIII–X in control testes) (Fig.
5 F and G and Fig. S5C). We confirmed our identification of lep-
totene spermatocytes throughout this broad range of stages by
immunostaining for meiotic markers: γH2AX (phosphorylated H2A
histone family member X, a marker of DNA double strand breaks)
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Fig. 4. STRA8 protein is normally present in late
undifferentiated spermatogonia and can be pre-
cociously induced by injected RA. (A) Whole-mount
immunostaining of intact wild-type testis tubules
for PLZF (red) and STRA8 (green), in controls (Left)
and 1 d after RA injection (Right). Arrowheads:
isolated (single) spermatogonia. Dashed lines: pu-
tative interconnected chains of spermatogonia.
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(Scale bar, 30 μm.) (E and F) Percentage of PLZF-
positive cells (E) or PLZF-negative premeiotic cells
(F) that are also positive for STRA8 in testis cross-
sections, in controls or 1 d after RA injection. Pre-
meiotic germ cells (In+B+Pl): intermediate and type
B spermatogonia and preleptotene spermatocytes.
Error bars, mean ± SD *P < 0.01 (one-tailed Welch’s
t test).
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(39) and SYCP3 (synaptonemal complex protein 3) (40). Indeed, at
10.6 d after RA injection, leptotene spermatocytes in stages VI–X
were γH2AX- and SYCP3-positive (Fig. 6A). The stages at which
type B spermatogonia, preleptotene spermatocytes, and leptotene
spermatocytes appeared after RA injection were completely consis-
tent with spermatogonial differentiation having occurred throughout
stages II–VIII (Fig. S5 E–G and Table S2).
We conclude that injected RA induced precocious spermato-
gonial differentiation. The precociously differentiated sper-
matogonia then progressed into meiotic prophase, ahead of
schedule. Spermatogonial differentiation was limited to stages
II–VIII, whereas undifferentiated spermatogonia in stages IX–I
were seemingly unaffected by RA.
Injected RA Induces Precocious Meiotic Initiation. Because injected
RA induces precocious STRA8 expression in both premeiotic
cells and undifferentiated spermatogonia, and STRA8 is re-
quired for meiotic initiation, we hypothesized that injected RA
would also induce precocious meiotic initiation. In the unperturbed
testis, germ cells initiate meiosis in late stage VII and stage VIII
and then develop into leptotene spermatocytes 2 d later. Thus,
we expect a transient increase in leptotene spermatocytes at
2 d after RA injection. Indeed, leptotene spermatocytes were
present in an increased fraction of testis tubules, in a broader
range of stages (VII–X) than in control testes (VIII–X). The
percentage of tubules containing preleptotene spermatocytes
was correspondingly decreased (Fig. 5 H–K and Fig. S5H). The
precocious leptotene cells had normal meiotic γH2AX and
SYCP3 expression patterns (Fig. 6B). To confirm that precocious
meiotic initiation was a specific effect of RA–STRA8 signaling, we
used WIN18,446 to chemically block RA synthesis and inhibit
STRA8 expression (Fig. S5I). As expected, WIN18,446 prevented
meiotic initiation in preleptotene spermatocytes (Fig. S5 J and K).
We also confirmed that the precocious leptotene spermatocytes
could progress normally through meiosis (Fig. S6 and SI Results
and Discussion).
Our results show that premeiotic cells initiated meiosis pre-
cociously in response to injected RA and then progressed nor-
mally through meiosis, ahead of their usual schedule. However,
precocious meiotic initiation occurred in fewer tubules than
precocious spermatogonial differentiation (Fig. 5 B and J),
strongly suggesting that the window of competence for meiotic
initiation was narrower than that for spermatogonial differenti-
ation. Based on the stages in which leptotene spermatocytes,
zygotene spermatocytes, and meiotically dividing cells appeared
after RA injection, we calculate that precocious meiotic initia-
tion occurred in stage VI, and perhaps also in stages IV–V. This
contrasts with precocious spermatogonial differentiation, which
occurred throughout stages II–VI. Moreover, only premeiotic
cells, not undifferentiated spermatogonia, were able to initiate
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Fig. 5. Injected RA induces precocious spermatogo-
nial differentiation and meiotic initiation. (A) Diagram
of predicted germ-cell development after RA-induced
spermatogonial differentiation. (B, D, and F) Percent-
age of tubules containing type B spermatogonia (B),
preleptotene spermatocytes (D), or leptotene sper-
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(yellow). (Scale bars, 30 μm.) (H) Diagram of predicted
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(yellow) spermatocytes. (Scale bars, 30 μm.)
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meiosis directly in response to RA, as judged by the absence of
γH2AX and SYCP3 signals in type A spermatogonia, 2 d after RA
injection (Fig. 6B). Thus, the competencies of germ cells to
interpret the RA–STRA8 signal are distinct between undifferentiated
spermatogonia and premeiotic cells.
Competencies for Spermatogonial Differentiation and Meiotic
Initiation Are Limited to Distinct Subsets of Germ Cells. We set out
to verify these distinct competencies using more stringent criteria.
In the unperturbed testis, the seminiferous cycle lasts 8.6 d (i.e., in
a given tubule section, spermatogonial differentiation and meiotic
initiation occur once every 8.6 d) (Fig. 1B). We administered suc-
cessive RA injections, once per 8.6-d cycle (Fig. 7A). We then
predicted when different germ-cell types should appear, based
on our findings that competence for spermatogonial differenti-
ation was limited to stages II–VIII, that competence for meiotic
initiation was limited to a subset of these stages, and that germ cells
developed normally after precocious spermatogonial differentiation/
meiotic initiation.
Competence for meiotic initiation. We first predicted that premeiotic
cells in stages VI–VIII (and possibly also in stages IV/V), having
initiated meiosis, would develop into step 7–8 spermatids after
two 8.6-d intervals of RA injection (2 × 8.6 d) (Fig. 1B). Indeed,
an increased percentage of tubules contained step 7–8 spermatids;
step 6 spermatids were correspondingly depleted (Fig. S7A).
Step 2–5 spermatids were virtually unchanged, demonstrating
that meiotic initiation occurred specifically in stages VI–VIII,
not in stages IV–V.
Competence for spermatogonial differentiation. We next predicted
that spermatogonia in stages II–VIII, having differentiated,
would develop into step 7–8 spermatids after 3 × 8.6 d of RA
injection, then develop into spermatozoa after 4 × 8.6 d, and
finally be released into the tubule lumen (Fig. 1B). Indeed, we
saw increases in step 7–8 spermatids and spermatozoa after 3 ×
8.6 d and 4 × 8.6 d, respectively (Fig. 7 B and C and Fig. S7A).
Successive RA injections were able to repeatedly induce sper-
matogonial differentiation; at 4 × 8.6 d, spermatozoa combined
with younger RA-induced generations of germ cells to produce
an excess of stage VII/VIII germ-cell associations, with a cor-
responding depletion of stages II–VI (Fig. 7B). Finally, after
4 × 8.6 plus 2 d of RA injection (36.4 d total), an increased per-
centage of tubules had released their spermatozoa (Fig. S7 B–D).
All these results are entirely consistent with competence for sper-
matogonial differentiation being limited to stages II–VIII.
Competence for neither. Finally, because germ cells in stages IX–I
are competent for neither spermatogonial differentiation nor
meiotic initiation, they should be unaffected by successive RA
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injections. Indeed, after 4 × 8.6 d of RA injections, the frequency
of stage IX–I tubules was the same as in controls (Fig. 7B).
We found that, when germ cells are provided with RA, com-
petence to undergo spermatogonial differentiation is strictly
limited to stages II–VIII, whereas competence to undergo mei-
otic initiation is strictly limited to stages VI–VIII. The accuracy
of our predictions, over long time scales, demonstrated that
these windows of competence are precise. Furthermore, germ
cells were able to develop at their normal pace after precocious
spermatogonial differentiation/meiotic initiation. This development
occurred even when germ cells were outside of their usual cell as-
sociations. Injected RA is thus able to accelerate spermatogenesis.
Finally, we note that successive RA injections, combined with in-
trinsic germ-cell competencies, repeatedly induced spermatogonial
differentiation; four successive injections were thus able to rees-
tablish normal stage VII/VIII germ-cell associations (Fig. 7B andC).
We conclude that spermatogonial differentiation and meiotic initi-
ation are regulated by a shared RA–STRA8 signal intersecting with
two distinct germ-cell competencies (Fig. 7D).
Discussion
RA–STRA8 Signaling Coordinates Spermatogonial Differentiation and
Meiotic Initiation. Spermatogenesis in rodents is elaborately or-
ganized, with multiple generations of germ cells developing in
stereotypical cell associations. This organization was first
reported in 1888 (15) and by the 1950s had been comprehensively
described (13, 33, 41). To understand spermatogenesis, we must
systematically perturb its organization. Here, we used two com-
plementary perturbations, genetic ablation of Stra8 function and
chemical manipulation of RA levels, to probe the coordination of two
key transitions: spermatogonial differentiation and meiotic initiation.
We report that RA–STRA8 signaling plays an instructive role
in both spermatogonial differentiation and meiotic initiation,
inducing these transitions to occur together. Specifically, we
provide the first functional evidence to our knowledge that
STRA8, an RA target gene, promotes spermatogonial differen-
tiation (as well as being required for meiotic initiation) (24, 25).
In the absence of Stra8, spermatogonial differentiation was im-
paired: Undifferentiated spermatogonia began to accumulate as
early as p10, ultimately giving rise to massive accumulations of
type A spermatogonia in aged testes. These findings show that
RA acts instructively at spermatogonial differentiation, by al-
tering gene expression in spermatogonia. Genetic ablation of
Stra8 did not completely block spermatogonial differentiation,
indicating that RA must act through additional targets at this
transition. Additional targets could be activated either directly by
RARs in spermatogonia, or indirectly, by the action of RA on
the supporting somatic (Sertoli) cells of testis. Indeed, indirect
RA signaling, via RARα in Sertoli cells, is critical for the first
round of spermatogonial differentiation (42). We also report that,
in wild-type mice, RA injection induced precocious spermatogonial
differentiation and meiotic initiation. We infer that, in the un-
perturbed wild-type testis, a single pulse of RA signaling drives
STRA8 expression in both undifferentiated spermatogonia and
premeiotic spermatocytes and induces two distinct, cell-type-
specific responses. This shared RA–STRA8 signal helps to en-
sure that spermatogonial differentiation and meiotic initiation
occur at the same time and place (Fig. 7D).
Evidence of Elevated RA Concentration in Stages VII–XII/I. In any
given tubule cross-section, spermatogonial differentiation and
meiotic initiation occur periodically, once every 8.6 d. Sugimoto
et al. (43) and Hogarth et al. (44) have hypothesized that RA
concentration also varies periodically over the course of this
8.6-d cycle. This hypothesis is supported by expression data,
functional studies, and direct measurements of RA levels (34, 43,
45, 46). However, the pattern of RA periodicity was previously
unclear. Hogarth et al. (34, 44) suggested a sharp RA peak in
stages VIII–IX. In contrast, based on expression patterns of RA-
responsive genes and the functional consequences of inhibiting
RA signaling, Hasegawa and Saga (45) suggested that RA levels
rise in stage VII and remain high through stage XII.
Our data support the latter model, of a prolonged elevation of
RA levels (Fig. 7D). We and others (35) have demonstrated that,
in the unperturbed testis, STRA8 is periodically expressed and is
present for the majority of the seminiferous cycle. Specifically,
we show that STRA8 protein is present in spermatogonia in
stages VII–XII/I and absent in II–VI. Furthermore, we show
that, at the level of the tubule cross-section, spermatogonial
STRA8 expression marks the presence of RA: When we in-
creased RA levels by injecting RA or decreased them by
injecting WIN18,446, STRA8 expression was immediately induced
or repressed in all seminiferous stages (Fig. 4C). We thus agree
with and extend the model of Hasegawa and Saga (45): In the
unperturbed testis, RA levels rise in stage VII, rapidly inducing
STRA8 and then inducing spermatogonial differentiation and
meiotic initiation. RA levels remain high until stages XII/I. This
model of a long RA–STRA8 pulse is consistent with additional
published data. First, the enzyme Aldh1a2, which increases RA
levels, is strongly expressed in stages VII–XII, whereas the en-
zymes Lrat and Adfp, which reduce RA levels, are expressed in
stages I–VI/VII (43, 46). Second, although measured RA levels
seem to peak in stages VIII–IX, they remain elevated for an
extended period (2–4 d in pubertal animals, and through stage
XII in adults) (34). Despite these persistently elevated RA levels,
neither spermatogonial differentiation nor meiotic initiation re-
curs in stages IX–I. As we will now discuss, germ cells at these
later stages lack competence for these transitions.
Undifferentiated Spermatogonia and Premeiotic Cells Have Different
Competencies to Respond to RA–STRA8 Signaling. By examining
responses to exogenous RA, we provide functional evidence that
germ cells have periodic, stage-limited competencies to undergo
spermatogonial differentiation and meiotic initiation. These
competencies intersect with instructive, periodic RA–STRA8
signaling. Specifically, undifferentiated spermatogonia are com-
petent for spermatogonial differentiation in stages II–VIII, and
premeiotic cells are competent for meiotic initiation in stages
VI–VIII (Fig. 7D). Competencies for both transitions begin
while RA levels are low, so that the germ cells respond as soon as
RA levels rise. Competencies for both transitions end simulta-
neously, while RA levels are still high. Thus, germ-cell competencies
and high RA levels intersect briefly, causing spermatogonial dif-
ferentiation and meiotic initiation to occur at the same time and
place (in stages VII–VIII).
We also conclude that undifferentiated spermatogonia and
premeiotic cells enact different molecular and cellular programs
in response to RA–STRA8 signaling. In response to injected RA,
only preleptotene spermatocytes (and possibly late type B sper-
matogonia, the immediate precursors of preleptotene spermato-
cytes) began to express meiotic markers such as SYCP3 and
γH2AX. Undifferentiated spermatogonia were not competent to
initiate meiosis directly. Instead, in response to injected RA,
most late undifferentiated spermatogonia began a program of
spermatogonial differentiation, followed by six mitotic cell di-
visions. The early undifferentiated spermatogonia and a fraction
of the late undifferentiated spermatogonia were seemingly un-
affected by RA; they did not express STRA8 and did not dif-
ferentiate. We believe that these undifferentiated spermatogonia
are able to self-renew and proliferate even in the presence of
RA, preventing the pool of undifferentiated spermatogonia from
becoming depleted. Indeed, a normal complement of germ cells
remained after repeated RA injections, indicating that injected
RA did not eliminate the pool of undifferentiated spermatogo-
nia (which includes the spermatogonial stem cells). Thus, distinct
germ-cell competencies enable a single RA signal to induce both
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spermatogonial differentiation and meiotic initiation and ensure
that a subset of spermatogonia are able to self-renew and pro-
liferate despite exposure to the RA signal.
We do not yet know the molecular mechanism behind the
stage- and cell-type-specific competencies to differentiate in re-
sponse to RA. These competencies cannot simply be explained
by RAR expression, because the RARs do not have precise
stage-specific expression patterns. For instance, RARγ expres-
sion can be observed in all stages of the seminiferous cycle (21,
46). The competencies must therefore result from other aspects
of germ-cell state. We note that competence for spermatogonial
differentiation is closely correlated with proliferative activity.
Specifically, undifferentiated spermatogonia in stages II–VIII,
which are competent for differentiation, are arrested in the G0/G1
phase of the cell cycle, whereas undifferentiated spermatogonia
in stages IX–I are actively proliferating (10, 38). Further studies
are needed to identify the mechanisms by which competencies to
undergo spermatogonial differentiation, and then meiotic initi-
ation, are achieved.
The critical role for intrinsic germ-cell competence during
spermatogenesis is in some respects analogous to its role of
competence during oogenesis. In adult ovaries, immature oo-
cytes are arrested at the diplotene stage of meiotic prophase.
Some of these arrested oocytes grow and acquire intrinsic com-
petence to resume meiosis and then acquire competence to
mature (i.e., to progress to metaphase II arrest) (47, 48). These
serially acquired competencies intersect with extrinsic, hormonal
signals. We suggest that, in both oogenesis and spermatogenesis,
properly timed differentiation depends on the intersection of
extrinsic chemical cues and intrinsic competence.
RA–STRA8 Signaling Can Both Perturb and Reestablish the Complex
Organization of the Testis. We find that injected RA can induce
spermatogonial differentiation and meiotic initiation to occur
precociously and ectopically, outside of their normal context. In
the unperturbed testis, these two transitions occur together at
stages VII/VIII, but, following a single RA injection, they oc-
curred in different stages, with spermatogonial differentiation as
early as stage II and meiotic initiation as early as stage VI. Then,
when provided with RA at 8.6-d intervals, these precociously
advancing germ cells were able to complete meiosis and develop
into spermatozoa, ahead of schedule. This developmental flexi-
bility is surprising, given the seemingly rigid organization of
spermatogenesis (11). In the unperturbed testis, multiple gen-
erations of germ cells occur together in stereotypical associa-
tions; these associations are conserved across mammals and,
before this study, had proven difficult to chemically disrupt (43,
49, 50). Nevertheless, when provided with RA, germ cells pro-
ceeded through spermatogenesis, outside of their usual environs,
with no apparent guidance from the neighboring germ cells.
Why is spermatogenesis so precisely organized, if the stereo-
typical associations are not required for germ-cell development?
We posit that this precise organization is in part a by-product of
RA–STRA8 signaling (and germ-cell competencies): Cooccur-
rence of spermatogonial differentiation and meiotic initiation
nucleates the stereotypical germ-cell associations. In support of
this idea, when we administered successive RA injections at 8.6-d
intervals, to repeatedly drive precocious spermatogonial differ-
entiation and meiotic initiation, we were able to perturb and
reestablish the characteristic germ-cell associations in vivo. The
stereotypical associations, established by RA–STRA8 signaling,
may ensure the efficiency of spermatogenesis.
We conclude that a simple regulatory mechanism helps to
explain the testis’s extraordinary capacity for proliferation and
differentiation. Periodic RA signaling repeatedly induces sper-
matogonial differentiation and meiotic initiation, driving germ
cells toward becoming highly specialized haploid spermatozoa.
Meanwhile, distinct germ-cell competencies enforce that every
spermatogonium undergoes programmed amplifying divisions
before initiating meiosis, guaranteeing a prodigious output of
spermatozoa. Moreover, a fraction of spermatogonia undergo
neither spermatogonial differentiation nor meiotic initiation in re-
sponse to RA, ensuring that a reservoir of undifferentiated sper-
matogonia is maintained throughout the animal’s reproductive
lifetime. This basic understanding of the organization of sper-
matogenesis, derived from genetic and chemical perturbations,
will facilitate future studies of germ-cell development, RA-driven
differentiation, and cell competence, both in vivo and in vitro.
Materials and Methods
Mice. Three types of mice were used: wild-type (C57BL/6NtacfBR), Stra8-
deficient (extensively back-crossed to C57BL/6) (26, 27), and Dmc1-deficient
(B6.Cg-Dmc1tm1Jcs/JcsJ) (51). See SI Materials and Methods for strain and
genotyping details. Unless otherwise noted, experiments were performed
on 6- to 8-wk-old male mice, fed a regular (vitamin A-sufficient) diet. All
experiments involving mice were approved by the Committee on Animal
Care at the Massachusetts Institute of Technology.
Statistics. Data are represented as mean ± SD of three biological replicates.
To compare two groups, Welch’s t test (one- or two-tailed as indicated) or
the Mann–Whitney U test were used. To compare three or more groups,
one-way ANOVA with the Tukey–Kramer post hoc test was used. To com-
pare multiple experimental groups with a control group, one-way ANOVA
with Dunnett’s post hoc test was used. To compare distributions, the
Kolmogorov–Smirnov test was used. When performing genome-wide anal-
ysis of mRNA-Seq data, the Benjamini–Hochberg procedure was used to
control the false discovery rate.
mRNA-Seq Sample Preparation. Testes were stripped of the tunica albuginea,
placed in TRIzol (Invitrogen), homogenized, and stored at −20 °C. Total RNAs
were prepared according to the manufacturer’s protocol. Total RNAs were
then DNase-treated using DNA Free Turbo (Ambion). Libraries were pre-
pared using the Illumina mRNA-Seq Sample Preparation Kit according to
the manufacturer’s protocol. Libraries were validated with an Agilent Bio-
analyzer. Libraries were diluted to 10 pM and applied to an Illumina flow cell
using the Illumina Cluster Station. The Illumina Genome Analyzer II platform
was used to sequence 36-mers (single end) from the mRNA-Seq libraries.
mRNA-Seq and Microarray Data Analysis. For mRNA-Seq data, reads were
aligned to the mouse genome using TopHat (52). Analysis was performed
using edgeR (53), Cufflinks (54), and custom R scripts. Microarray data were
normalized with the GCRMA package from Bioconductor, and replicates
were averaged using limma (55). Comparison mRNA-Seq and microarray
datasets were downloaded from National Center for Biotechnology In-
formation GEO and Sequence Read Archive (SRA). See SI Materials and
Methods for details on mRNA-Seq and microarray data processing and
comparison.
Histology. Testes were fixed overnight in Bouin’s solution, embedded in
paraffin, sectioned, and stained with hematoxylin and eosin, or with he-
matoxylin and periodic acid-Schiff (PAS). All sections were examined using a
light microscope. Germ-cell types were identified by their location, nuclear
size, and chromatin pattern (11). See SI Materials and Methods for details
on identification of the stages of the seminiferous cycle.
Chemical Treatments. For RA injection experiments, mice received i.p. in-
jections of 100 μL of 7.5 mg/mL all-trans RA (Sigma-Aldrich) in 16% (vol/vol)
DMSO–H2O. For BrdU incorporation experiments, mice received i.p. in-
jections of 10 μL/g body weight of 10 mg/mL BrdU (Sigma-Aldrich) in PBS, 4 h
before they were killed. For WIN18,446 injection experiments, mice received
i.p. injections of 100 μL of 20 mg/mL WIN18,446 (sc-295819A; Santa Cruz
Biotechnology) in 16% DMSO–H2O; mice were dosed at intervals of 12 h for
a total of 2 or 4 d.
Immunostaining on Testis Sections. Testes were fixed overnight in Bouin’s
solution or 4% (wt/vol) paraformaldehyde, embedded in paraffin, and sec-
tioned at 5-μm thickness. Slides were dewaxed, rehydrated, and heated in
10 mM sodium citrate buffer (pH 6.0). Sections were then blocked, incubated
with the primary antibody, washed with PBS, incubated with the sec-
ondary antibody, and washed with PBS. Detection was fluorescent or
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colorimetric. Antibodies and incubation conditions are provided in SI
Materials and Methods and in Table S3.
Immunostaining on Intact Testis Tubules. Testes were stripped of the tunica
albuginea, dispersed in PBS, fixed overnight in 4% paraformaldehyde at 4 °C,
and washed with PBS. Testes were blocked with 2.5% (vol/vol) donkey se-
rum, incubated with the primary antibody, washed with PBS, incubated with
the secondary antibody, and washed with PBS. Finally, seminiferous tubules
were dissected from testes and mounted with SlowFade Gold antifade re-
agent with DAPI (S36939; Life Technologies). Antibodies and incubation
conditions are provided in SI Materials and Methods.
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